As citrus greening continues to impact Florida’s groves, growers have found that they need a way to quickly and accurately count the amount of fruit dropped early to help identify problem areas, which will save time and money.
With funding from the Bill and Melinda Gates Foundation, researchers from the University of Florida will be better armed to fight cholera and malaria in Haiti. Both diseases pose serious public health threats to the population.
At the peak of the Ebola epidemic last fall came a frightening new possibility: a mutation that could allow the disease to spread through the air. Now University of Florida researchers have dispelled this concern using data from current and past Ebola outbreaks.
A University of Florida scientist will try to figure out how antibiotic-resistant microorganisms get into cattle. Another will study how to get tomatoes and strawberries to retain their flavors and last longer.
The waning number of Ebola cases is good news for West Africa, but for those developing a vaccine for the disease, it means time is running short.
Five years after the worst environmental disaster in U.S. history, communities along the Gulf of Mexico continue to struggle with the aftermath of the Deepwater Horizon oil spill, according to University of Florida researchers engaged in a series of projects funded by the National Institute of Environmental Health Sciences.
On Monday, the Emerging Pathogens Institute partnered up with UF Institute of Food and Agricultural Sciences, Bob Graham Center for Public Service, UF/IFAS Center for Public Issues Education, and Healthy Gulf, Healthy Communities Project to host “Five Years Later — Lessons Learned from the Deepwater.” The event took place at 6 p.m. in The Bob Graham Center for Public Service.
Recently, University of Florida Health researchers discovered why an influenza virus was making young people admitted to UF Health Shands Hospital so sick: It contained a mutation that allowed it to infect the patients’ lower respiratory tracts.
Implementing a vaccine trial during an epidemic can be difficult, particularly in countries with poor transportation, limited vaccine supplies and difficulty predicting how widespread a disease may become — conditions such as those in West Africa during the recent Ebola outbreak.
Alaska salmon are winners; Alaska salmon fishermen – not so much.
